Literature DB >> 31427763

Remission in rheumatoid arthritis: missing objectives by using inadequate DAS28 targets.

Daniel Aletaha1, Josef S Smolen2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31427763     DOI： 10.1038/s41584-019-0279-6

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  12 in total

1.  Development and validation of equations for conversion from DAS28ESR and DAS28CRP to the SDAI in patients with rheumatoid arthritis.

Authors:  Li-Ming Pu; Yin Liu; De-Xin Zhou; Xi-Jia Tang; Chao-Nan Fan; Wen Chen; Jian-da Ma; Jian-Zi Lin; Lie Dai; Li Ling
Journal:  Clin Rheumatol       Date:  2022-08-10       Impact factor: 3.650

2.  Using a DAS28-CRP-steered treat-to-target strategy does not eliminate subclinical inflammation as assessed by ultrasonography in rheumatoid arthritis patients in longstanding clinical remission.

Authors:  Lene Terslev; Cecilie Heegaard Brahe; Mikkel Østergaard; Viktoria Fana; Mads Ammitzbøll-Danielsen; Torsten Møller; Simon Krabbe; Merete Lund Hetland; Uffe Møller Døhn
Journal:  Arthritis Res Ther       Date:  2021-02-01       Impact factor: 5.156

3.  Time-averaged disease activity of rheumatoid arthritis associated with long-term bone mineral density changes.

Authors:  Chung-Yuan Hsu; Jia-Feng Chen; Yu-Jih Su; Ying-Chou Chen; Han-Ming Lai; Shan-Fu Yu; Hsiao-Ru He; Tien-Tsai Cheng
Journal:  Ther Adv Chronic Dis       Date:  2020-12-23       Impact factor: 5.091

Review 4.  Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations.

Authors:  Amit Garg; Neeta Malviya; Andrew Strunk; Shari Wright; Afsaneh Alavi; Raed Alhusayen; Ali Alikhan; Steven D Daveluy; Isabelle Delorme; Noah Goldfarb; Wayne Gulliver; Iltefat Hamzavi; Tarannum Jaleel; Alexa B Kimball; Joslyn S Kirby; Mark G Kirchhof; Janice Lester; Hadar Lev-Tov; Michelle A Lowes; Robert Micheletti; Lauren A Orenstein; Vincent Piguet; Christopher Sayed; Jerry Tan; Haley B Naik
Journal:  J Am Acad Dermatol       Date:  2021-01-23       Impact factor: 15.487

5.  Reexamining remission definitions in rheumatoid arthritis: considering the twenty-eight-joint Disease Activity Score, C-reactive protein level and patient global assessment.

Authors:  David Felson; Diane Lacaille; Michael P LaValley; Daniel Aletaha
Journal:  RMD Open       Date:  2021-11

6.  The Aftermath of Tapering Tocilizumab After Achieving Treatment Target in Patients With Rheumatoid Arthritis: A Nationwide Cohort Study.

Authors:  Jun Won Park; Min Jung Kim; Hyoun-Ah Kim; Jin Hyun Kim; Eun Bong Lee; Kichul Shin
Journal:  Front Med (Lausanne)       Date:  2022-02-08

7.  Reexamining Remission Definitions in Rheumatoid Arthritis: Considering Disease Activity Score in 28 Joints, C-Reactive Protein, and Patient Global Assessment.

Authors:  David T Felson; Diane Lacaille; Michael P LaValley; Daniel Aletaha
Journal:  ACR Open Rheumatol       Date:  2021-11-16

8.  Limiting factors to Boolean remission differ between autoantibody-positive and -negative patients in early rheumatoid arthritis.

Authors:  Serena Bugatti; Ludovico De Stefano; Antonio Manzo; Garifallia Sakellariou; Blerina Xoxi; Carlomaurizio Montecucco
Journal:  Ther Adv Musculoskelet Dis       Date:  2021-05-22       Impact factor: 5.346

9.  Radiographic progression based on baseline characteristics from TNF inhibitor biosimilar studies in patients with rheumatoid arthritis.

Authors:  Josef S Smolen; Young Mo Kang; Wan-Hee Yoo; Paul Emery; Michael E Weinblatt; Edward C Keystone; Mark C Genovese; Gihyun Myung; Inyoung Baek; Jeehoon Ghil
Journal:  Arthritis Res Ther       Date:  2020-08-14       Impact factor: 5.156

10.  Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement.

Authors:  Peter Nash; Andreas Kerschbaumer; Thomas Dörner; Maxime Dougados; Roy M Fleischmann; Klaus Geissler; Iain McInnes; Janet E Pope; Désirée van der Heijde; Michaela Stoffer-Marx; Tsutomu Takeuchi; Michael Trauner; Kevin L Winthrop; Maarten de Wit; Daniel Aletaha; Xenofon Baraliakos; Wolf-Henning Boehncke; Paul Emery; John D Isaacs; Joel Kremer; Eun Bong Lee; Walter P Maksymowych; Marieke Voshaar; Lai-Shan Tam; Yoshiya Tanaka; Filip van den Bosch; René Westhovens; Ricardo Xavier; Josef S Smolen
Journal:  Ann Rheum Dis       Date:  2020-11-06       Impact factor: 19.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.